Although the upregulation of mTORC1 and proinflammatory signaling in the psap KO brain supports the targeting of these pathways for sphingolipidosis treatment, the current RNA sequencing was performed at the symptomatic end stage of disease and did not yield temporal information on the relative occurrences of disease-associated events. This evidence concerns the gene PSAP and sphingolipidosis.